SELLAS Life Sciences Group, Inc. (SLS) Stock Total Returns
Growth of $10,000 chart
2021-04-21 to 2026-04-21 to
$
%
%
Loading chart…
Investment Performance
Final Value
$6,395
Total Return
-36.05%
CAGR
-8.55%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +3.74% |
| Median | +0.61% |
| Best | +223.81% |
| Worst | -67.86% |
| % of Windows Positive | 50.3% |
1-Year (252 Trading Days)
| Average | +4.19% |
| Median | -25.33% |
| Best | +402.65% |
| Worst | -85.11% |
| % of Windows Positive | 34.4% |
3-Year (756 Trading Days)
| Average | -33.05% |
| Median | -67.03% |
| Best | +313.93% |
| Worst | -91.81% |
| % of Windows Positive | 16.8% |
Risk Metrics
| Maximum Drawdown | -96.25% |
| Average Drawdown | -76.33% |
| Drawdown Duration | 1207 Trading Days (Unrecovered) |
| Sortino Ratio | 0.57 |
| Calmar Ratio | -0.09 |
| CVaR (5%) | -13.68% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +33.43% (+158.29% ann.) | +$3342.62 | $0.00 | $0.00 | $0.00 |
| 2025 | +262.63% | +$26262.63 | $0.00 | $0.00 | $0.00 |
| 2024 | -1.98% | $198.02 | $0.00 | $0.00 | $0.00 |
| 2023 | -55.11% | $5511.11 | $0.00 | $0.00 | $0.00 |
| 2022 | -57.31% | $5730.55 | $0.00 | $0.00 | $0.00 |
| 2021 | -4.70% | $470.16 | $0.00 | $0.00 | $0.00 |
| 2020 | +34.88% | +$3487.80 | $0.00 | $0.00 | $0.00 |
| 2019 | -93.00% | $9299.98 | $0.00 | $0.00 | $0.00 |
| 2018 | -84.23% | $8423.12 | $0.00 | $0.00 | $0.00 |
| 2017 | -86.60% | $8659.79 | $0.00 | $0.00 | $0.00 |
| 2016 partial | -72.29% (-92.17% ann.) | $7228.57 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | June 29, 2016 – February 19, 2020 | -99.98% | -90.07% | $9997.77 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -25.35% | -96.44% | $2534.56 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +54.88% | +102.16% | +$5487.80 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +158.96% | +146.63% | +$15896.41 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -26.79% | -28.19% | $2679.13 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -74.68% | -52.34% | $7468.35 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 21, 2026 | +312.93% | +144.26% | +$31293.10 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.